参考文献/References:
[1] Rosen PP, Saigo PE, Braun DW,et al.Prognosis in stage II(T1N1M0)breast cancer[J].Ann Surg,1981,194(5):576-584.
[2] González-Vela MC,Garijo MF,Fernández FA,et al.Predictors of axillary lymph node metastases in patients with invasive breast carcinoma by a combination of classical and biological prognostic factors[J].Pathol Res Pract,1999,195(9):611-618.
[3] Tan LG,Tan YY,Heng D,et al.Predictors of axillary lymph node metastases in women with early breast cancer in Singapore[J].Singapore Medical Journal,2006,46(12):693-697.
[4] Port ER,Tan LK,Borgen PI,et al.Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma[J].Ann Surg Oncol,1998,5(1):23-27.
[5] Quint LE. Imaging of anterior mediastinal masses[J].Cancer Imaging,7(Spec No A):S56-62.
[6] Lee AH,Pinder SE,Macmillan RD,et al.Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma[J].EurJ Cancer,2006,42(3):357-362.
[7] Lyman GH,Giuliano AE,Somerfield MR,et al.Am-erican Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer[J].J Clin Oncol,2005,23(30):7703-7720.
[8] Carcoforo P,Maestroni U,Querzoli P,et al.Primary breast cancer features can predict additional lymph node involvement in patiets with sentinel node micrometastases[J].World Journal of Surgery,2006,30(9):1653-1657.
[9] Mustac E,Matusan-Ilijas K,Marijic B,et al.Predicting the likelihoodof additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy[J].Int J Surg Pathol,2010,18(1):36-41.
[10] Wasif N,Ye X,Giuliano AE,et al.Survey of ASCO members on management of sentinel node micrometastases in breast cancer:variation in treatment recommendations according to specialty[J].Annals of Surgical Oncology,2009,16(9):2442-2449.
[11] Park K, Kwak K, Kim J,et al.C-myc amplification is associated withHER2 amplification and closely linked with cell?proliferation in tissue miroarray of nonselected breast cancers[J].Hum Pathol,2005,36(6):634-639.
相似文献/References:
[1]王 倩,劳淑贞,朴金松,等.乳腺良恶性肿瘤组织中CD44的表达及其与淋巴管生成的关系[J].现代检验医学杂志,2018,33(04):16.[doi:10.3969/j.issn.1671-7414.2018.04.005]
WANG Qian,LAO Shu-zhen,PIAO Jin-song,et al.Expression of CD44 in Benign and Malignant Breast Tumors
and Its Relationship with Lymphangiogenesis[J].Journal of Modern Laboratory Medicine,2018,33(03):16.[doi:10.3969/j.issn.1671-7414.2018.04.005]
[2]林帝金,刘纯岳,方俊粤,等.乳腺肿瘤患者外周血中T淋巴细胞表面活化分子和Tregs的表达研究[J].现代检验医学杂志,2018,33(05):31.[doi:10.3969/j.issn.1671-7414.2018.05.009]
LIN Di-jin,LIU Chun-yue,FANG Jun-yue,et al.Expression of T Lymphocyte Surface Activating Molecules and Tregs in Peripheral Blood of Patients with Breast Neoplass[J].Journal of Modern Laboratory Medicine,2018,33(03):31.[doi:10.3969/j.issn.1671-7414.2018.05.009]